Alcohol Metabolism & Methanol Poisoning | Fatty Liver, Hypoglycemia, Fomepizole

Added:

Transcriptional and Inflammatory Regulators vs. The NADH/NAD+ Redox Model of Fatty Liver

While classic biochemistry attributes alcoholic fatty liver disease primarily to the metabolic redox shift (where high NADH/NAD+ ratios directly slow down beta-oxidation), modern hepatology offers an alternative, systemic paradigm. Emerging research suggests that this redox imbalance alone is insufficient for sustained liver injury. Instead, contemporary models emphasize transcriptional dysregulation—such as the activation of lipogenic SREBP-1c and suppression of PPAR-alpha—and the gut-liver axis. Alcohol-induced gut dysbiosis and increased intestinal permeability allow bacterial endotoxins (LPS) to enter portal circulation. This triggers Kupffer cells via TLR4 pathways to release pro-inflammatory cytokines like TNF-alpha, which drive cellular damage and lipid accumulation. This perspective shifts the student's focus from a simple metabolic bottleneck to a complex genomic and inflammatory disease model.

Basic enzymatic biochemistry, specifically how dehydrogenases function and the role of NAD+/NADH cofactors in cellular redox reactions.
The metabolic pathways of glycolysis, gluconeogenesis, and the citric acid (Krebs) cycle, including how they are regulated by the cellular energy state.
Fundamentals of lipid metabolism, particularly fatty acid synthesis and beta-oxidation within the liver.
The concept of competitive inhibition in pharmacology, where different substrates compete for the same enzyme active site.
Clinical diagnosis and management of toxic alcohol ingestions, including calculating the anion gap and osmolar gap in an emergency setting.
The progression of alcoholic liver disease, tracing the pathophysiology from steatosis (fatty liver) to alcoholic hepatitis and irreversible cirrhosis.
The biochemical pathophysiology of high anion gap metabolic acidosis (HAGMA) induced by toxic metabolites like formic acid and glycolic acid.
Pharmacological treatments for alcohol use disorder, such as the mechanism of Disulfiram (Antabuse) in inhibiting aldehyde dehydrogenase.
57.7K views649likes13:48@stomponstep1989Original Release: 2014-06-11

Ethanol is metabolized by alcohol dehydrogenase to acetaldehyde, then by acetaldehyde dehydrogenase to acetate; this process generates NADH which disrupts normal metabolism by decreasing gluconeogenesis and fat oxidation while increasing anaerobic glycolysis, leading to hypoglycemia, lactic acidosis, and fatty liver changes. Methanol poisoning is treated with fomepizole (which inhibits alcohol dehydrogenase) or ethanol (which competitively inhibits the same enzyme), preventing the toxic conversion of methanol to formaldehyde.